Dr. Osei-Wusu provides critical input into the strategy, development and implementation of studies in the company’s cardiovascular program. She has represented Novartis at both the American College of Cardiology and the American Heart Association Scientific Congresses. And is also an active member of Women of Color in Pharma. Over the last year, she has partnered with the Novartis Public Affairs team to participate in numerous federal and state-focused policy events to help spotlight health disparities within the cardiovascular space and increase diversity in clinical trials.
Dr. Abena Osei-Wusu
